Can Valproic Acid be an Inducer of Clozapine Metabolism?

被引:42
作者
Diaz, F. J. [1 ]
Eap, C. B. [2 ,3 ]
Ansermot, N. [2 ]
Crettol, S. [2 ]
Spina, E. [4 ]
de Leon, J. [5 ,6 ]
机构
[1] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS 66103 USA
[2] Univ Lausanne, Hosp Cery, Dept Psychiat, Unit Pharmacogenet & Clin Psychopharmacol,Ctr Psy, Prilly, Switzerland
[3] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland
[4] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[5] Eastern State Hosp, Mental Hlth Res Ctr, Lexington, KY 40511 USA
[6] Univ Granada, Inst Neurosci, Psychiat & Neurosci Res Grp CTS 549, Granada, Spain
关键词
clozapine; pharmacokinetics; metabolism; enzyme induction; drug interactions; therapeutic drug monitoring; valproic acid; smoking; tobacco; random-effects linear model; SERUM CONCENTRATIONS; DRUG-INTERACTIONS; CYP1A2; ACTIVITY; CO-MEDICATIONS; PLASMA; OLANZAPINE; DOSAGE; PHARMACOKINETICS; POLYMORPHISMS; POPULATION;
D O I
10.1055/s-0034-1371866
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Prior clozapine studies indicated no effects, mild inhibition or induction of valproic acid (VPA) on clozapine metabolism. The hypotheses that (i) VPA is a net inducer of clozapine metabolism, and (ii) smoking modifies this inductive effect were tested in a therapeutic drug monitoring study. Methods: After excluding strong inhibitors and inducers, 353 steady-state total clozapine (clozapine plus norclozapine) concentrations provided by 151 patients were analyzed using a random intercept linear model. Results: VPA appeared to be an inducer of clozapine metabolism since total plasma clozapine concentrations in subjects taking VPA were significantly lower (27% lower; 95% confidence interval, 14-39%) after controlling for confounding variables including smoking (35% lower, 28-56%). Discussion: Prospective studies are needed to definitively establish that VPA may (i) be an inducer of clozapine metabolism when induction prevails over competitive inhibition, and (ii) be an inducer even in smokers who are under the influence of smoking inductive effects on clozapine metabolism.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 54 条
  • [1] American Pharmacist Association, 2012, DRUG INFORM HDB
  • [2] A mechanistic approach to antiepileptic drug interactions
    Anderson, GD
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) : 554 - 563
  • [3] Valproate lowers plasma concentration of olanzapine
    Bergemann, Niels
    Kress, Kai R.
    Abu-Tair, Fatima
    Frick, Alex
    Kopitz, Juergen
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (04) : 432 - 434
  • [4] Estimating the effects of co-medications on plasma olanzapine concentrations by using a mixed model
    Botts, Sheila
    Diaz, Francisco J.
    Santoro, Vincenza
    Spina, Edoardo
    Muscatello, Maria R.
    Cogollo, Myladis
    Castro, Fidel E.
    de Leon, Jose
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2008, 32 (06) : 1453 - 1458
  • [5] CENTORRINO F, 1994, AM J PSYCHIAT, V151, P123
  • [6] Valproic acid induces CYP3A4 and MDR1 gene expression by activation of constitutive androstane receptor and pregnane X receptor pathways
    Cerveny, Lukas
    Svecova, Lucie
    Anzenbacherova, Eva
    Vrzal, Radim
    Staud, Frantisek
    Dvorak, Zdenek
    Ulrichova, Jitka
    Anzenbacher, Pavel
    Pavek, Petr
    [J]. DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) : 1032 - 1041
  • [7] Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients
    Chang, WH
    Lin, SK
    Lane, HY
    Wei, FC
    Hu, WH
    Lam, YWF
    Jann, MW
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1998, 22 (05) : 723 - 739
  • [8] The Transcriptional Regulation of the Human CYP2C Genes
    Chen, Yuping
    Goldstein, Joyce A.
    [J]. CURRENT DRUG METABOLISM, 2009, 10 (06) : 567 - 578
  • [9] Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS
    Choong, Eva
    Rudaz, Serge
    Kottelat, Astrid
    Guillarme, Davy
    Veuthey, Jean-Luc
    Eap, Chin B.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 50 (05) : 1000 - 1008
  • [10] Pharmacokinetics of aripiprazole and concomitant lithium and valproate
    Citrome, L
    Josiassen, R
    Bark, N
    Salazar, DE
    Mallikaarjun, S
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (01) : 89 - 93